Intercell: Restructuring Is Progressing

CompaniesHealth Care ♦ Published: August 16, 2011; 10:54 ♦ (Vindobona)

Sales of the company’s only product on the market increased by 85% in the first six months of the year. Net loss was down 44.2%.

Intercell: Restructuring Is Progressing / Picture: © Intercell

The listed vaccine producer Intercell on Tuesday presented results for the second quarter and the first half of 2011. Revenue increased by 27.5% to € 18.38m from January to June. Net loss was reduced by 44.2% and amounted to € 12.9m which is still 70% of revenue.

Sales of the company’s only product currently on the market, a vaccine to prevent Japanese Encephalitis…